Abstract
Acetylation of α-tubulin was studied in cultures of human hepatocytes under the influence of selective inhibitors of histone deacetylases HDAC6 and SIRT-2 — tubastatin A and 2-(3-phenethoxyphenylamino)benzamide, respectively. It was found that in hepatocyte cell line HepG2 acetylated α-tubulin is accumulated preferentially on inhibition of HDAC6 but not of SIRT-2. Under the same conditions, no acetylation of α-tubulin was observed in hepatocyte cell line Huh7. However, the inhibition of HDAC6 with tubastatin A led to hyperacetylation of α-tubulin and simultaneously to decrease in viral RNA concentration in hepatocyte cell line Huh7-luc/neo, which supports propagation of the full genome replicon of hepatitis C virus. The correlation between these two processes points to HDAC6 as a promising cellular target for therapy of hepatitis C.
Similar content being viewed by others
Abbreviations
- HCV:
-
hepatitis C virus
- HDAC6:
-
Zn2+-dependent histone deacetylase 6
- MT:
-
microtubules
- SIRT-2:
-
NAD+-dependent histone deacetylase
- αTAT1:
-
α-tubulin acetyltransferase of mammals
References
Singh, B. N., Zhang, G., Hwa, Y. L., Li, J., Sean, C., Dowdy, S. C., and Jiang, S. W. (2010) Nonhistone protein acetylation as cancer therapy targets, Expert Rev. Anticancer Ther., 10, 935–954.
Shida, T., Cueva, J. G., Xu, Z., Goodman, M. B., and Nachury, M. V. (2010) The major α-tubulin K40 acetyltransferase αTAT1 promotes rapid ciliogenesis and efficient mechanosensation, PNAS, 107, 21517–21522.
Matsuyama, A., Shimazu, T., Sumida, Y., Saito, A., Yoshimatsu, Y., Seigneurin-Berny, D., Osada, H., Komatsu, Y., Nishino, N., Khochbin, S., Horinouchi, S., and Yoshida, M. (2002) In vivo destabilization of dynamic microtubules by HDAC6-mediated deacetylation, EMBO J., 21, 6820–6831.
Hubbert, C., Guardiola, A., Shao, R., Kawaguchi, Y., Ito, A., Nixon, A., Yoshida, M., Wang, X. F., and Yao, T. P. (2002) HDAC6 is a microtubule-associated deacetylase, Nature, 417, 455–458.
North, B. J., Marshall, B. L., Borra, M. T., Denu, J. M., and Verdin, E. (2003) The human Sir2 ortholog, SIRT2, is an NAD+-dependent tubulin deacetylase, Mol. Cell, 11, 437–444.
Nahhas, F., Dryden, S. C., Abrams, J., and Tainsky, M. A. (2007) Mutations in SIRT2 deacetylase which regulate enzymatic activity but not its interaction with HDAC6 and tubulin, Mol. Cell. Biochem., 303, 221–230.
Janke, C., and Bulinski, J. C. (2011) Posttranslational regulation of the microtubule cytoskeleton: mechanisms and functions, Nat. Rev. Mol. Cell Biol., 12, 773–786.
Zilberman, Y., Ballestrem, C., Carramusa, L., Mazitschek, R., Khochbin S., and Bershadsky, A. (2009) Regulation of microtubule dynamics by inhibition of the tubulin deacetylase HDAC6, J. Cell Sci., 122, 3531–3541.
Witt, O., Deubzer, H. E., Milde, T., and Oehme, I. (2009) HDAC family: what are the cancer relevant targets? Cancer Lett., 277, 8–21.
Simoes-Pires, C., Zwick, V., Nurisso, A., Schenker, E., Carrupt, P. A., and Cuendet, M. (2013) HDAC6 as a target for neurodegenerative diseases: what makes it different from the other HDACs? Mol. Neurodegener., 8, 7–22.
Taes, I., Timmers, M., Hersmus, N., Bento-Abreu, A., Van Den Bosch, L., Van Damme, P., Auwerx, J., and Robberecht, W. (2013) Hdac6 deletion delays disease progression in the SOD1G93A mouse model of ALS, Hum. Mol. Genet., 22, 1783–1790.
Roohvand, F., Maillard, P., Lavergne, J. P., Boulant, S., Walic, M., Andreo, U., Goueslain, L., Helle, F., Mallet, A., McLauchlan, J., and Budkowska, A. (2009) Initiation of hepatitis C virus infection requires the dynamic microtubule network, J. Biol. Chem., 284, 13778–13791.
Bost, A. G., Venable, D., Liu, L., and Heinz, B. A. (2003) Cytoskeletal requirements for hepatitis C virus (HCV) RNA synthesis in the HCV replicon cell culture system, J. Virol., 77, 4401–4408.
Lai, C. K., Jeng, K. S., Machida, K., and Lai, M. M. (2008) Association of hepatitis C virus replication complexes with microtubules and actin filaments is dependent on the interaction of NS3 and NS5A, J. Virol., 82, 8838–8848.
Wolk, B., Buchele, B., Moradpour, D., and Rice, C. M. (2008) A dynamic view of hepatitis C virus replication complexes, J. Virol., 82, 10519–10531.
Sato, A., Saito, Y., Sugiyama, K., Sakasegawa, N., Muramatsu, T., Fukuda, S., Yoneya, M., Kimura, M., Ebinuma, H., Hibi, T., Ikeda, M., Kato, N., and Saito, H. (2013) Suppressive effect of the histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA) on hepatitis C virus replication, J. Cell. Biochem., 114, 1987–1996.
Kozlov, M. V., Kleymenova, A. A., Romanova, L. I., Konduktorov, K. A., Smirnova, O. A., Prasolov, V. S., and Kochetkov, S. N. (2013) Benzohydroxamic acids as potent and selective anti-HCV agents, Bioorg. Med. Chem. Lett., 23, 5936–5940.
Kozlov, M. V., Kleymenova, A. A., Konduktorov, K. A., and Kochetkov, S. N. (2013) A new synthesis of a highly selective inhibitor of histone deacetylase 6-N-hydroxy-4-(2-methyl-1,2,3,4-tetrahydropyrido[4,3-b]indol-5-ylmethyl)benzamide — tubastatin A, Bioorg. Khim., 39, 117–120.
Suzuki, T., Khan, M. N., Sawada, H., Imai, E., Itoh, Y., Yamatsuta, K., Tokuda, N., Takeuchi, J., Seko, T., Nakagawa, H., and Miyata, N. (2012) Design, synthesis, and biological activity of a novel series of human sirtuin-2-selective inhibitors, J. Med. Chem., 55, 5760–5773.
Wagner, F. F., Olson, D. E., Gale, J. P., Kaya, T., Weiver, M., Aidoud, N., Thomas, M., Davoine, E. L., Lemercier, B. C., and Holson, E. B. (2013) Potent and selective inhibition of histone deacetylase 6 (HDAC6) does not require a surface-binding motif, J. Med. Chem., 56, 1772–1776.
Butler, K. V., Kalin, J., Brochier, C., Vistoli, G., Langley, B., and Kozikowski, A. P. (2010) Rational design and simple chemistry yield of a superior, neuroprotective HDAC6 inhibitor, tubastatin A, J. Am. Chem. Soc., 132, 10842–10846.
Kovacs, J. J., Murphy, P., Gaillard, S., Zhao, X., Wu, J. T., Nicchitta, C. V., Yoshida, M., Toft, D. O., Pratt, W. B., and Yao, T. P. (2005) HDAC6 regulates Hsp90 acetylation and chaperone-dependent activation of glucocorticoid receptor, Mol. Cell., 18, 601–607.
Ujino, S., Yamaguchi, S., Shimotohno, K., and Takaku, H. (2009) Heat-shock protein 90 is essential for stabilization of the hepatitis C virus nonstructural protein NS3, J. Biol. Chem., 284, 6841–6846.
Parmigiani, R. B., Xu, W. S., Venta-Perez, G., Erdjument-Bromage, H., Yaneva, M., Tempst, P., and Marks, P. A. (2008) HDAC6 is a specific deacetylase of peroxiredoxins and is involved in redox regulation, PNAS, 105, 9633–9638.
Waris, G., Turkson, J., Hassanein, T., and Siddiqui, A. (2005) Hepatitis C virus (HCV) constitutively activates STAT-3 via oxidative stress: role of STAT-3 in HCV replication, J. Virol., 79, 1569–1580.
Wyles, D. (2012) Beyond telaprevir and boceprevir: resistance and new agents for hepatitis C virus infection, Top Antivir. Med., 20, 139–145.
Author information
Authors and Affiliations
Corresponding author
Additional information
Original Russian Text © M. V. Kozlov, A. A. Kleymenova, K. A. Konduktorov, A. Z. Malikova, S. N. Kochetkov, 2014, published in Biokhimiya, 2014, Vol. 79, No. 7, pp. 802–808.
Originally published in Biochemistry (Moscow) On-Line Papers in Press, as Manuscript BM14-067, May 25, 2014.
Rights and permissions
About this article
Cite this article
Kozlov, M.V., Kleymenova, A.A., Konduktorov, K.A. et al. Selective inhibitor of histone deacetylase 6 (tubastatin A) suppresses proliferation of hepatitis C virus replicon in culture of human hepatocytes. Biochemistry Moscow 79, 637–642 (2014). https://doi.org/10.1134/S0006297914070050
Received:
Revised:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S0006297914070050